Holen Sie sich die Stockscreener-App
4.505
1.10%
-0.055
Schlusskurs vom Vortag:
$4.56
Offen:
$4.44
24-Stunden-Volumen:
471.61K
Relative Volume:
0.78
Marktkapitalisierung:
$436.93M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-238.77M
KGV:
-0.168
EPS:
-26.808
Netto-Cashflow:
$-216.62M
1W Leistung:
-6.24%
1M Leistung:
+12.19%
6M Leistung:
-1.74%
1J Leistung:
-60.51%
1-Tages-Spanne:
$4.41
$4.65
1-Wochen-Bereich:
$4.385
$4.85
52-Wochen-Spanne:
$2.7601
$13.00
Alumis Inc Stock (ALMS) Company Profile
Firmenname
Alumis Inc
Sektor
Branche
Telefon
650-231-6625
Adresse
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Vergleichen Sie ALMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALMS
Alumis Inc
|
4.51 | 474.53M | 0 | -238.77M | -216.62M | -26.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
430.00 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.61 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
426.45 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
842.17 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.92 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Alumis Inc Stock (ALMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-25 | Eingeleitet | Wells Fargo | Overweight |
| 2025-06-10 | Fortgesetzt | Guggenheim | Buy |
| 2025-01-30 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-31 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-10-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-23 | Eingeleitet | Guggenheim | Buy |
| 2024-07-23 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-23 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Alumis Inc Aktie (ALMS) Neueste Nachrichten
Alumis to Participate in Upcoming November Investor Conferences - The Manila Times
Alumis (Nasdaq: ALMS) schedules investor conference webcasts, replays for 90 days - Stock Titan
Analyzing drawdowns of Alumis Inc. with statistical toolsJuly 2025 WrapUp & Daily Profit Focused Stock Screening - newser.com
Is a relief rally coming for Alumis Inc. holdersWeekly Loss Report & Verified Stock Trade Ideas - newser.com
Real time scanner hits for Alumis Inc. explainedJuly 2025 Highlights & Real-Time Market Sentiment Alerts - newser.com
Will Alumis Inc. continue its uptrendQuarterly Performance Summary & Target Return Focused Stock Picks - newser.com
Will Alumis Inc. stock remain a Wall Street favoriteFed Meeting & Daily Growth Stock Tips - newser.com
Will Alumis Inc. stock benefit from upcoming earnings reportsQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
How to manage a losing position in Alumis Inc.Weekly Stock Report & Consistent Profit Trade Alerts - newser.com
Why Alumis Inc. stock is recommended by analystsJuly 2025 Macro Moves & Entry Point Confirmation Signals - newser.com
Will Alumis Inc. stock benefit from sector rotationJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
Momentum divergence signals in Alumis Inc. chart2025 Short Interest & Daily Profit Focused Screening - newser.com
Is Alumis Inc. a candidate for recovery playQuarterly Market Summary & Weekly Chart Analysis and Guides - newser.com
Chart based exit strategy for Alumis Inc.2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com
Is Alumis Inc. stock positioned for long term growthJuly 2025 PostEarnings & Stepwise Swing Trade Plans - newser.com
Pattern recognition hints at Alumis Inc. upsideJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Will Alumis Inc. outperform the marketMarket Movers & Free Real-Time Volume Trigger Notifications - newser.com
Tools to assess Alumis Inc.’s risk profileJuly 2025 Action & Free Growth Oriented Trading Recommendations - newser.com
Alumis Inc.’s ESK-001 Study: A Potential Game-Changer in Psoriasis Treatment - MSN
Sentiment Watch: Will Alumis Inc. stock outperform value stocksJuly 2025 Opening Moves & Free Technical Confirmation Trade Alerts - Fundação Cultural do Pará
Finanzdaten der Alumis Inc-Aktie (ALMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Alumis Inc-Aktie (ALMS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tananbaum James B. | Director |
May 06 '25 |
Buy |
4.34 |
20,000 |
86,800 |
4,247,670 |
| Foresite Labs, LLC | 10% Owner |
May 02 '25 |
Buy |
4.62 |
25,000 |
115,500 |
4,227,670 |
| Foresite Labs, LLC | 10% Owner |
May 06 '25 |
Buy |
4.34 |
20,000 |
86,800 |
4,247,670 |
| Foresite Capital Management VI | 10% Owner |
May 02 '25 |
Buy |
4.62 |
25,000 |
115,500 |
4,227,670 |
| Foresite Capital Management VI | 10% Owner |
May 06 '25 |
Buy |
4.34 |
20,000 |
86,800 |
4,247,670 |
| AKKARAJU SRINIVAS | Director |
May 05 '25 |
Buy |
4.67 |
160,370 |
749,676 |
3,586,788 |
| AKKARAJU SRINIVAS | Director |
May 02 '25 |
Buy |
4.55 |
159,920 |
727,636 |
3,426,418 |
| Colowick Alan | Director |
Apr 01 '25 |
Buy |
6.97 |
16,104 |
112,309 |
16,104 |
| Colowick Alan | Director |
Apr 02 '25 |
Buy |
7.49 |
2,300 |
17,235 |
18,404 |
| Babler Martin | President, CEO and Chairman |
Apr 01 '25 |
Buy |
6.44 |
15,650 |
100,733 |
106,454 |
1.90%
0.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):